EPIGET

Epirubicin is classified as an anthracycline antibiotic and is preferred for its significantly lower cardiotoxicity which makes it safer for elderly patients with breast cancer.

Epirubicin is classified as an anthracycline antibiotic and is preferred for its significantly lower cardiotoxicity which makes it safer for elderly patients with breast cancer.

Indication:

As a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer

Generic Name

Strength

Standard

Type

Packing

Pack Size

Epirubicin

10 mg

BP

INJ

Vial

Vial

Epirubicin

50 mg

BP

INJ

Vial

Vial